エピソード

  • The Ripple Effects of Tariffs and Transfer Pricing on Global Business
    2025/09/10

    In this episode, Mike Burke, AGG Corporate partner and chair of the International Practice, welcomes back Sean King, president and founder of Align Global Consulting and the podcast’s very first guest. Mike and Sean discuss how companies can strategically manage tariffs and transfer pricing, while also examining the ripple effects across supply chains, intellectual property, and global tax structures. The conversation highlights opportunities amid uncertainty, from reassessing supply chains and customs valuation to evaluating whether the U.S. itself is becoming a “tax haven.”

    続きを読む 一部表示
    29 分
  • Navigating U.S.-China Relations: Lessons From History for Today’s Global Economy
    2025/08/28

    In this episode, Mike Burke, AGG Corporate & Finance partner and chair of the firm’s International practice, welcomes lawyer and author Amy Sommers for an insightful discussion on the shifting landscape of U.S.-China relations. Drawing on her 40 years of engagement with China — including more than a decade advising multinational companies in Shanghai — Amy reflects on lessons from history, parallels to the autumn of 1950, and the challenges and opportunities global businesses face amid today’s economic and geopolitical uncertainties.

    Mike and Amy discuss the impacts of tariffs, supply chain disruptions, demographic shifts, and regulatory unpredictability, as well as the evolving role of states and CEOs in shaping international investment. They also consider what U.S. companies can learn from navigating China’s complex business environment and how those lessons apply to today’s increasingly fragmented global economy.

    続きを読む 一部表示
    36 分
  • How International Companies Can Prepare for July 9 Tariffs
    2025/06/26

    In this episode, Mike Burke, AGG Corporate & Finance partner and co-chair of the firm’s International practice, is joined by Allison Raley, AGG partner and member of the International practice, to explore the U.S. tariff changes slated for July 9, 2025.

    Mike and Allison analyze the legal and strategic considerations international companies must weigh, including the potential impact of new tariffs under Section 232 investigations. From contract renegotiation and supply chain review to long-term manufacturing decisions, this episode offers timely guidance to help companies proactively mitigate risk.

    続きを読む 一部表示
    23 分
  • How Life Sciences Companies Can Create a Culture of Compliance When Expanding to the U.S. Market
    2025/04/30

    In this episode, Mike Burke, AGG Corporate partner and co-chair of the firm’s International practice, is joined by David Blank, AGG Healthcare partner, to discuss how foreign life sciences companies can proactively address healthcare compliance challenges when expanding into the U.S. market.

    Mike and David cover key fraud and abuse laws, including the False Claims Act, the Anti-Kickback Statute, Physician Self-Referral Law (Stark law), and the Civil Monetary Penalties Law, and highlight common mistakes companies make and the severe penalties for non-compliance. As regulatory issues can be incredibly costly and disruptive to a business, Mike and David emphasize the importance of establishing a strong compliance culture from the start.

    続きを読む 一部表示
    27 分
  • U.S. Healthcare Reimbursement Guidance for Foreign Life Sciences Companies
    2025/03/20

    In this episode, Mike Burke, AGG Corporate partner and co-chair of the firm’s International practice, is joined by Andrew Tsui, AGG Healthcare Litigation partner, to explore the intricacies of reimbursement in the U.S. healthcare system. Mike and Andrew discuss challenges foreign life sciences companies face related to Medicare and Medicaid reimbursement, the regulatory hurdles involved, and common pitfalls to avoid. They also highlight the importance of understanding compliance requirements, enforcement mechanisms, and the role of federal agencies in shaping payment determinations.

    続きを読む 一部表示
    32 分
  • U.S. Enforcement Trends Targeting Foreign Pharmaceutical and Medical Device Manufacturers
    2025/03/06

    AGG Corporate partner and co-chair of the firm’s International practice, Mike Burke, is joined by Gabe Scannapieco, AGG Litigation & Dispute Resolution partner, to discuss enforcement trends affecting foreign pharmaceutical and medical device manufacturers. Mike and Gabe explore the increasing regulatory scrutiny on overseas facilities, the role of U.S. agencies in compliance and inspections, and practical steps companies can take to mitigate legal and operational risks when entering the U.S. market.

    続きを読む 一部表示
    27 分
  • Venture Capital Trends and Fundraising Strategies for Foreign Startups Expanding to the U.S.
    2025/02/12

    In this episode, Mike Burke, AGG Corporate partner and co-chair of the firm’s International practice, is joined by Paula Nagarajan, AGG Corporate partner, to discuss trends in the U.S. venture capital market and fundraising considerations for foreign startups expanding across borders. Mike and Paula highlight varying investment approaches and industry focuses in different geographic regions in the U.S., the importance of strong formation documents, and strategies for securing funding. They also highlight practical steps that founders can implement when pitching their company and building valuable industry relationships.

    続きを読む 一部表示
    26 分
  • Preparing Employers for Immigration Policy Changes Under the Trump Administration
    2025/01/09

    In this episode, Mike Burke, AGG Corporate partner and co-leader of the firm’s International practice, is joined by Teri Simmons, AGG Global Mobility chair, to discuss potential changes under the Trump administration to business immigration policies and the impact on foreign nationals working in the United States. Mike and Teri address critical compliance strategies for employers, risks posed by potential travel bans and temporary protected status revocations, and heightened scrutiny on work visas. They also provide guidance on how companies can prepare for audits and enforcement actions while minimizing business disruptions.

    続きを読む 一部表示
    31 分